Thierry Heles, editor of Global University Venturing, takes an alternate look at one of last week's corporate venturing deals.
Aprea, a biotech spinout of Sweden’s Karolinska Institute working on cancer treatments, raised Skr437m ($51m) last week, making it the largest funding round secured by a Karolinska Development portfolio company to date.
The deal, which is also the biggest funding round raised by any Sweden-based life sciences company in the past decade, was co-led by VC firms Versant Ventures and 5AM Ventures and also featured Sectoral Asset Management and HealthCap.
Karolinska Development, the investment arm of Karolinska Institute, participated…
